日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SHR-A1811, a novel HER2-targeting antibody-drug conjugate, in advanced solid tumors (HORIZON-X): a global phase 1 trial

SHR-A1811,一种新型靶向 HER2 的抗体药物偶联物,在晚期实体瘤中的应用(HORIZON-X):一项全球 1 期试验

Yao, Herui; Yan, Min; Tong, Zhongsheng; Wu, Xinhong; Yin, Yongmei; Ryu, Min-Hee; Park, John J; Jiang, Shusuan; Kim, Jee Hyun; Wang, Shouman; Zhong, Yahua; Voskoboynik, Mark; Zhang, Jian; Kaubisch, Andreas; Liu, Caigang; Chen, Yu; Im, Seock-Ah; Wu, Lingying; Liu, Yingbin; Ganju, Vinod; Barve, Minal; Li, Hui; Yao, Guangyu; Yang, Mudan; Bao, Lequn; Zhao, Yiming; Zhao, Jianli; Zhao, Kaijing; Shen, Yu; Rong, Shangyi; Zhu, Xiaoyu; Song, Erwei

Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2 positive metastatic breast cancer: long term survival results from randomised phase 3 PHILA trial

吡咯替尼或安慰剂联合曲妥珠单抗和多西他赛治疗HER2阳性转移性乳腺癌:随机3期PHILA试验的长期生存结果

Ma, Fei; Yan, Min; Li, Wei; Ouyang, Quchang; Tong, Zhongsheng; Teng, Yuee; Wang, Yongsheng; Wang, Shusen; Geng, Cuizhi; Luo, Ting; Zhong, Jincai; Zhang, Qingyuan; Liu, Qiang; Zeng, Xiaohua; Sun, Tao; Mo, Qinguo; Zhou, Shoubing; Li, Peidong; Cheng, Jing; Wang, Xiaojia; Nie, Jianyun; Yang, Jin; Wu, Xinhong; Wang, Xinshuai; Li, Huiping; Yao, Guangyu; Fan, Yang; Lin, Jiaman; Zhu, Xiaoyu; Xu, Binghe

Reversibly unlocking the blood-brain barrier: A study on microtubule dynamics modulation using gold nanoparticle-modified reduced graphene oxide.

可逆地解锁血脑屏障:利用金纳米粒子修饰的还原氧化石墨烯调控微管动力学的研究。

Wu Junrong, Cui Guangman, Lin Zhousheng, Lin Wanmei, Zhang Yaqing, Zhou Tianhang, He Ping, Zhang Yunjiao, Yao Guangyu

An Early-Stage Nuclear Protein in Testis Carcinoma of the Lung in an Older Woman

老年女性睾丸肺癌早期核蛋白

Shan, Guangyao; Zeng, Dejun; Huang, Wen; Yao, Guangyu

NAT10-mediated lipid metabolic reprogramming drives EGFR-TKI resistance in non-small cell lung cancer via ac4C-dependent mRNA stabilization

NAT10介导的脂质代谢重编程通过ac4C依赖的mRNA稳定作用驱动非小细胞肺癌的EGFR-TKI耐药性

Fang, Shuai; Zhu, Yuchao; Chen, Wei; Mao, Wei; Fang, Yuan; Chen, Ziyuan; Hong, Zhiqi; Zhao, Xiaodong; Su, Wenmin; Pan, Yuning; Yao, Guangyu; Wang, Jianhua; Zhou, Chengwei

Sarcosine sensitizes lung adenocarcinoma to chemotherapy by dual activation of ferroptosis via PDK4/PDHA1 signaling and NMDAR-mediated iron export.

肌氨酸通过 PDK4/PDHA1 信号传导和 NMDAR 介导的铁输出双重激活铁死亡,使肺腺癌对化疗更加敏感

Shan Guangyao, Bian Yunyi, Ren Shencheng, Hu Zhengyang, Pan Binyang, Zeng Dejun, Zheng Zhaolin, Fan Hong, Bi Guoshu, Yao Guangyu, Zhan Cheng

Microbiota-directed lactic acid depleting nanoenzyme reactivates antitumor immunity and chemosensitivity in hypoxic tumor

微生物群导向的乳酸清除纳米酶可重新激活乏氧肿瘤的抗肿瘤免疫和化疗敏感性

Lan, Xinyue; Zhang, Fengling; Cui, Guangman; Hu, Ben; Lai, Yufang; Lin, Huimin; Huang, Huiqi; Zhou, Dan; Yu, Meng; Yao, Guangyu

Retinol-driven Gene Signatures Predict Lung Adenocarcinoma Outcomes and Highlight PAICS as a Therapeutic Opportunity

视黄醇驱动的基因特征预测肺腺癌预后,并凸显PAICS作为一种治疗契机

Shan, Guangyao; Pan, Binyang; Zhang, Yongxing; Ren, Shencheng; Zheng, Zhaolin; Bian, Yunyi; Yao, Guangyu; Fan, Hong

Long-term outcome of neoadjuvant tislelizumab plus chemotherapy in locally advanced esophageal squamous cell carcinoma

新辅助替雷利珠单抗联合化疗治疗局部晚期食管鳞状细胞癌的长期疗效

Yin, Hao; Yang, Xinyu; Chen, Yujie; Duan, Hongtao; Wang, Jie; Liao, Xuqiang; Yao, Guangyu; Liang, Fei; Fan, Hong; Li, Gao; Sun, Yihua; Yan, Xiaolong; Wang, Peiyuan; Tan, Lijie

Breast cancer burden (1990-2040) in individuals aged 55 and above: a GBD 2021 analysis of global trends, sex-specific risk factors, and intervention impact

1990-2040年55岁及以上人群乳腺癌负担:基于GBD 2021的全球趋势、性别特异性风险因素和干预措施影响分析

Jian, Shimao; Lin, Wanmei; Tang, Yuewen; Yao, Guangyu